| AD | Atopic dermatitis |
| AMCi | Atrial Natriuretic Peptide-Modulating Cytotoxicity Inhibitor |
| AMP | Antimicrobial peptide |
| BNP | Brain natriuretic peptide |
| CGRP | Calcitonin gene-related peptide |
| CKD | Chronic kidney disease |
| CoNS | Coagulase-negative staphylococci |
| CTCL | Cutaneous T-cell lymphoma |
| DRG | Dorsal root ganglia |
| FDA | U.S. Food and Drug Administration |
| FFA | Free fatty acid |
| FLG | Filaggrin |
| IL | Interleukin |
| JAK | Janus kinase |
| KLK | Kallikrein |
| LSC | Lichen simplex chronicus |
| MRGPR | Mas-related G protein-coupled receptor |
| NMF | Natural moisturizing factor |
| PAR | Protease-activated receptor |
| PN | Prurigo nodularis |
| SCFA | Short chain fatty acid |
| SIR | Standardized incidence ratio |
| STAT | Signal transducer and activator of transcription |
| TEWL | Transepidermal water loss |
| TLR | Toll-like receptor |
| TRP | Transient receptor potential |
| TRPV1/3/4 | Transient receptor potential vanilloid channels 1, 3, and 4 |
| TSLP | Thymic stromal lymphopoietin |
| VIP | Vasoactive intestinal peptide |